IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Thursday reported second-quarter net income of $489.5 million, after reporting a loss in the same period a year earlier.

The Irvine, California-based company said it had net income of 78 cents per share. Earnings, adjusted for non-recurring gains, came to 64 cents per share.

The results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 55 cents per share.

The medical device maker posted revenue of $1.38 billion in the period, also surpassing Street forecasts. Nine analysts surveyed by Zacks expected $1.29 billion.

For the current quarter ending in October, Edwards Lifesciences expects its per-share earnings to range from 50 cents to 56 cents.

The company said it expects revenue in the range of $1.29 billion to $1.37 billion for the fiscal third quarter.

Edwards Lifesciences expects full-year earnings in the range of $2.07 to $2.27 per share, with revenue ranging from $5.2 billion to $5.4 billion.

Edwards Lifesciences shares have risen 22% since the beginning of the year, while the S&P's 500 index has risen 18%. In the final minutes of trading on Thursday, shares hit $111.62, a climb of 41% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EW at https://www.zacks.com/ap/EW

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News